MedPath

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Completed
Conditions
Parkinson Disease
Registration Number
NCT00617019
Lead Sponsor
Boehringer Ingelheim
Brief Summary

The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3234
Inclusion Criteria

Observation Criteria:

Male or female outpatients, aged 30 to 75 years of age, with idiopathic PD. Patients must be selected on the basis of a prospective recruitment plan documented at the site, with the objective of obtaining an unbiased representative sample.

Patients must have been treated with anti-parkinson medication for a period of one year or greater and demonstrated a treatment response, in the opinion of the Investigator.

Patients must be willing and able to comply with study procedures. Patients must be willing and able to give meaningful, written informed consent. This must be completed prior to beginning any study procedures, in accordance with GCP and local legislation.

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Occurrence of current ImpulseControl Disorder(ICD) assessed via + res. of Modif.Massachusetts Gambling Screen,Modif.Minnesota Impulsive Disorder Interview for Sexuality,Modif.MIDI for Compulsive Buying,DSM-IV binge-eating research criteria questionnaire6 months
Secondary Outcome Measures
NameTimeMethod
The occurrence of a past (since onset of PD) ICD6 months
Demographic and medical history measuresup to 14 days after Visit 1
Scores on psychiatric/neuropsychological instruments/testsup to 14 days after Visit 1

Trial Locations

Locations (49)

248.619.01034 Neurological Physicians of Arizona

🇺🇸

Gilbert, Arizona, United States

248.619.01007 Mayo Clinic - Scottsdale

🇺🇸

Scottsdale, Arizona, United States

248.619.01025 Sun Health Research Institute

🇺🇸

Sun City, Arizona, United States

248.619.01018 Margolin Brain Institute

🇺🇸

Fresno, California, United States

248.619.01031 Pacific Neuroscience Medical Group, Inc.

🇺🇸

Oxnard, California, United States

248.619.01016 San Francisco VA PD Research, Education, & Clinical Center

🇺🇸

San Francisco, California, United States

248.619.01023 The Parkinson's Institute

🇺🇸

Sunnyvale, California, United States

248.619.01021 Boehringer Ingelheim Investigational Site

🇺🇸

Englewood, Colorado, United States

248.619.01027 Associated Neurologists, P.C.

🇺🇸

Danbury, Connecticut, United States

248.619.01013 Molecular NeuroImaging

🇺🇸

New Haven, Connecticut, United States

Scroll for more (39 remaining)
248.619.01034 Neurological Physicians of Arizona
🇺🇸Gilbert, Arizona, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.